JESSICA DIJULIO: Open Payments
NPI 1578046603 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,716 in 178 payments from 21 companies in 2025. Trend: 2023 $10,398 · 2024 $25,176 · 2025 $8,716
Speaker / faculty: $6,075Food & beverage: $2,641
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $6,306 |
| ABBVIE INC. | 46 | $557 |
| Organon LLC | 19 | $296 |
| Novartis Pharmaceuticals Corporation | 16 | $231 |
| Botanix SB Inc | 20 | $231 |
| GENZYME CORPORATION | 6 | $172 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $170 |
| LEO Pharma Inc. | 7 | $147 |
| Galderma Laboratories, L.P. | 6 | $108 |
| Amgen Inc. | 5 | $94 |
Products named: TREMFYA, SKYRIZI, SOFDRA, DUPIXENT, RINVOQ, COSENTYX, ILUMYA, VTAMA.
Industry payments across PA — which companies pay providers there.
